Clinical trial Intelligence for contract research organizations
We help CROs win business and enhance drug development services. Make better-informed decisions while bidding on and implementing clinical trials.
There are some trials that could be great for your business and others that might not be. But without high-quality intelligence, it can be hard to assess or maximize a trial’s potential.
How we help
Our thorough and extensive clinical trial intelligence for CROs will help your organization:
We’ll help you identify companies active in your territory and their phases of development. Spot where to run trials, with our data on where comparator trials have been approved and the availability of regional investigators.
You can size up competing trials, because we monitor and benchmark them, prioritizing investigators and tracking enrollment. And to help you mitigate risks, we can provide intelligence on safety issues faced by trials of similar designs.
By Ian Lloyd 13 Mar 2018
Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.
By Laura Runkel 21 Feb 2018
Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.
07 Jan 2018
November is National Alzheimer’s Disease (AD) Awareness Month. Sitetrove wants to raise awareness by going purple! This infographic offers an overview of the current global investigator landscape and how AD trial experience has shifted over the last 10 years
05 Jan 2018
Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.
By Christina DeRuzza 24 Nov 2017
China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.
10 Oct 2017
The UK has some of the world’s most exciting science, a supportive business environment, and strong companies led by experienced management teams.
By Doro Shin 09 Aug 2017
Breast cancer trials are making the most use of personalized medicine developments in trials, according to data gathered by Trialtrove.
17 Jul 2017
Using exclusive data from Citeline’s Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.
Topic Clinical trials
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: